PA
COGT icon

Perceptive Advisors’s Cogent Biosciences COGT Stock Holding History

Perceptive Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.66M Hold
121,082
– – 0.09% 76
2025
Q4 		$4.3M Buy
+121,082
New +$3.4M 0.08% 98
2024
Q2 		– Sell
-883,333
Closed -$5.94M – 117
2024
Q1 		$5.94M Sell
883,333
-239,625
-21% -$1.48M 0.1% 82
2023
Q4 		$6.6M Sell
1,122,958
-1,186,512
-51% -$9.09M 0.15% 70
2023
Q3 		$22.5M Sell
2,309,470
-350,000
-13% -$4.15M 0.75% 38
2023
Q2 		$31.5M Buy
2,659,470
+377,146
+17% +$4.33M 0.91% 35
2023
Q1 		$24.6M Sell
2,282,324
-925,117
-29% -$11.8M 0.73% 40
2022
Q4 		$37.1M Hold
3,207,441
– – 1.04% 28
2022
Q3 		$47.9M Buy
3,207,441
+118,469
+4% +$1.62M 1.39% 19
2022
Q2 		$27.9M Sell
3,088,972
-99,778
-3% -$681K 0.87% 27
2022
Q1 		$23.9M Hold
3,188,750
– – 0.48% 49
2021
Q4 		$27.4M Hold
3,188,750
– – 0.42% 57
2021
Q3 		$26.8M Hold
3,188,750
– – 0.39% 61
2021
Q2 		$25.9M Hold
3,188,750
– – 0.34% 74
2021
Q1 		$28M Hold
3,188,750
– – 0.35% 64
2020
Q4 		$35.8M Buy
3,188,750
+1,200,000
+60% +$13.2M 0.38% 58
2020
Q3 		$18.6M Buy
+1,988,750
New +$20.7M 0.27% 70

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Perceptive Advisors's COGT Position: Q1 2026 in Review

Perceptive Advisors held its Cogent Biosciences (COGT) position steady in Q1 2026 at 121,082 shares worth $4.66M. The position accounts for 0.09% of the portfolio, ranked #76.

Perceptive Advisors first reported a position in COGT in Q3 2020 and has held it in 17 quarters since. The position peaked at $47.9M in Q3 2022. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Perceptive Advisors held 121,082 shares of Cogent Biosciences worth $4.66M as of Q1 2026.
  • Perceptive Advisors left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up 0.09% of Perceptive Advisors's portfolio in Q1 2026, its #76 holding.
  • Perceptive Advisors first reported a position in Cogent Biosciences in Q3 2020 and has held it in 17 quarters since.
  • Perceptive Advisors's Cogent Biosciences position peaked at $47.9M in Q3 2022.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.